These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31801787)

  • 1. Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
    Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T; ;
    Diabetes Care; 2020 Feb; 43(2):314-320. PubMed ID: 31801787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Matsumoto C; Soejima H; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y;
    Diabetes Care; 2018 Aug; 41(8):1757-1764. PubMed ID: 29909377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
    Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
    Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
    Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
    JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
    Okada S; Morimoto T; Ogawa H; Kanauchi M; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sakuma M; Saito Y;
    Diabetes Care; 2011 Jun; 34(6):1277-83. PubMed ID: 21515838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.
    Saito Y; Morimoto T; Ogawa H; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sugiyama S; Okada S; Akai Y;
    Diabetes Care; 2011 Feb; 34(2):280-5. PubMed ID: 21270185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
    Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Jinnouchi H; Waki M; Akai Y; Ishii H; Saito Y;
    PLoS One; 2016; 11(1):e0147635. PubMed ID: 26808136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: subanalysis from the JPAD trial.
    Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Sakuma M; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2013 Sep; 62(3):165-70. PubMed ID: 23778008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
    Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Uemura S; Kanauchi M; Doi N; Sakuma M; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    Circ J; 2012; 76(6):1526-32. PubMed ID: 22447019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes.
    Okada S; Morimoto T; Ogawa H; Soejima H; Matsumoto C; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y
    J Gen Intern Med; 2021 Mar; 36(3):632-639. PubMed ID: 33063203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized control trial comparing the effect of cilostazol and aspirin on changes in carotid intima-medial thickness.
    Hong S; Nam M; Little BB; Paik S; Lee K; Woo J; Kim D; Kang J; Chun M; Park Y
    Heart Vessels; 2019 Nov; 34(11):1758-1768. PubMed ID: 31056733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus.
    Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T
    BMJ Open Diabetes Res Care; 2022 Mar; 10(2):. PubMed ID: 35361621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-Dependent Effect of Aspirin Use in Reducing Diabetes-Associated Dementia Risk Among Elderly Patients With Type 2 Diabetes Mellitus.
    Sun M; Chen WM; Wu SY; Zhang J
    J Am Med Dir Assoc; 2024 May; 25(5):889-897.e2. PubMed ID: 38642589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does aspirin use reduce cardiovascular risk in diabetes?
    Colwell JA
    Nat Rev Endocrinol; 2009 Apr; 5(4):188-90. PubMed ID: 19352314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
    Pradhan AD; Cook NR; Manson JE; Ridker PM; Buring JE
    Diabetes Care; 2009 Jan; 32(1):3-8. PubMed ID: 18835953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Series, clinical study from Japan and its reflections; Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial].
    Ogawa H
    Nihon Naika Gakkai Zasshi; 2011 Jan; 100(1):218-23. PubMed ID: 21387659
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.
    Solomon DH; Libby P; Yeomans ND; Wang Q; Wolski KE; Nissen SE; Husni ME
    Rheumatology (Oxford); 2018 Aug; 57(8):1364-1369. PubMed ID: 29688503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients at high risk.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Sugiyama S; Jinnouchi H; Waki M; Doi N; Horii M; Kawata H; Somekawa S; Soeda T; Uemura S; Saito Y;
    Circ J; 2013; 77(12):3023-8. PubMed ID: 24042256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.